EDU 23 - Molecular Intelligence in Breast Cancer Radiation Therapy
MODERATOR(S)
Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University
session DESCRIPTION
Molecular testing is an integral component of multidisciplinary management of breast cancer. Recent evidence underscores the importance of molecular assays in radiation therapy decision making. In addition to their prognostic and predictive benefits, such assays are increasingly utilized for escalation or de-escalation of radiation therapy. The current session will review emerging evidence supporting the use of molecular tests in early stage in-situ and invasive breast cancer. Current and future clinical trials on the topic will be presented.
learning objectives
- Assess the utility of molecular tests in radiotherapy decision making.
- Discuss the prognostic and predictive impact of molecular tests in early stage breast cancer.
Credits
| AMA PRA Category 1 Credits: | 1.25 |
| CAMPEP Credits: | 1.25 |
| MDCB Credits: | 1.25 |
Presentations
-
10:45am - 10:47am PTSpeaker: Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University , Boca Raton
-
10:45am - 12:00pm PTSpeaker: Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University , Boca Raton
-
10:47am - 11:02am PTSpeaker: Eileen Connolly, MD, PhD - New York Presbyterian Hospital Columbia Campus, New York
-
11:02am - 11:17am PTSpeaker: Corey Speers, MD, PhD - University of Alabama Birmingham School of Medicine, Birmingham
-
11:17am - 11:32am PTSpeaker: Atif Khan, MD, MS - Memorial Sloan Kettering Cancer Center, New York
-
11:32am - 11:45am PTSpeaker: Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University , Boca Raton